The pharmaceutical landscape is witnessing a shift with the introduction of GLP-1 transdermal systems . These cutting-edge formulations offer a promising method to providing glucagon-like peptide-1 therapies for individuals managing hyperglycemia. Instead of needles, a easy-to-use patch applied t